Wednesday, April 29, 2015

Results Comparison of stage 3/stage 2 identified 62 metabolites that differed flow wrapper ( P 0.05


Vallabh O. Shah * , Raymond R. Townsend , Harold I. Feldman , Kirk L. Pappan , Elizabeth flow wrapper Kensicki , David L. Vander Jagt * * University of New Mexico Health Sciences Center, Albuquerque, New Mexico; Perelman School of Medicine, University of Pennsylvania, Philadelphia, flow wrapper Pennsylvania; and Metabolon Inc., Durham, North Carolina Correspondence: Dr. Vallabh O. Shah, Department of Biochemistry and Molecular Biology, School of Medicine, University of New Mexico Health Sciences Center, 1 University of New Mexico, MSC08 4670, Albuquerque, NM 87131 . Email: vshah{at}salud.unm.edu
Background and objectives CKD is a common public health problem. Identifying biomarkers adds prognostic/diagnostic value by contributing to an understanding of CKD at the molecular level and possibly defining new drug targets. Metabolomics provides a snapshot of biochemical events at a particular time in the progression of CKD. This cross-sectional metabolomics study ascertained whether plasma metabolite flow wrapper profiles are significantly different in CKD stages 2, 3, and 4.
Design, setting, participants, & measurements An analysis of plasma metabolites, using gas and liquid chromatography coupled to mass spectrometry, was conducted on 30 nondiabetic men ages 40 52 years, with 10 participants each in CKD stages 2, 3, and 4 based on their estimated GFR (calculated by the Modified Diet in Renal Disease formula). flow wrapper Participants were recruited in late 2008, and plasma samples were tested at Metabolon Inc and analyzed in 2012.
Results Comparison of stage 3/stage 2 identified 62 metabolites that differed flow wrapper ( P 0.05), with 39 higher and 23 lower in stage 3 compared with stage 2; comparisons of stage 4/stage 2 identified 111 metabolites, with 66 higher and 45 lower; and comparisons of stage 4/stage 3 identified 11 metabolites, with 7 higher and 4 lower. Major differences in metabolite profiles with increasing stage of CKD were observed, including altered arginine metabolism, elevated coagulation/inflammation, impaired carboxylate anion transport, and decreased adrenal steroid hormone production.
Services Email this article to a colleague Alert me when this article is cited Alert me if a correction is posted Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Download to citation manager


No comments:

Post a Comment